THSD7A (NM_015204) Human Untagged Clone

CAT#: SC316606

THSD7A (untagged)-Human thrombospondin, type I, domain containing 7A (THSD7A)



  "NM_015204" in other vectors (6)

CNY 31,920.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (4)
THSD7A Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>SC316606 representing NM_015204.
Blue=Insert sequence Red=Cloning site Green=Tag(s)

GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG
GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC
ATGGGGCTGCAAGCCAGGCGCTGGGCGTCCGGGAGCCGGGGCGCTGCGGGGCCGCGCCGGGGCGTCCTG
CAGCTGCTGCCGCTGCCGCTGCCGCTGCCGCTGCTCCTGCTGCTGCTGCTACGCCCGGGCGCCGGCAGG
GCTGCGGCGCAGGGCGAGGCGGAGGCGCCCACCCTCTATCTGTGGAAGACTGGTCCATGGGGCCGATGT
ATGGGAGATGAATGTGGTCCCGGAGGCATCCAAACGAGGGCTGTGTGGTGTGCTCATGTGGAGGGATGG
ACTACACTGCATACTAACTGTAAGCAGGCCGAGAGACCCAATAACCAGCAGAATTGTTTCAAAGTTTGC
GATTGGCACAAAGAGTTGTACGACTGGAGACTGGGACCTTGGAATCAGTGTCAGCCCGTGATTTCAAAA
AGCCTAGAGAAACCTCTTGAGTGCATTAAGGGGGAAGAAGGTATTCAGGTGAGGGAGATAGCGTGCATC
CAGAAAGACAAAGACATTCCTGCGGAGGATATCATCTGTGAGTACTTTGAGCCCAAGCCTCTCCTGGAG
CAGGCTTGCCTCATTCCTTGCCAGCAAGATTGCATCGTGTCTGAATTTTCTGCCTGGTCCGAATGCTCC
AAGACCTGCGGCAGCGGGCTCCAGCACCGGACGCGTCATGTGGTGGCGCCCCCGCAGTTCGGAGGCTCT
GGCTGTCCAAACCTGACGGAGTTCCAGGTGTGCCAATCCAGTCCATGCGAGGCCGAGGAGCTCAGGTAC
AGCCTGCATGTGGGGCCCTGGAGCACCTGCTCAATGCCCCACTCCCGACAAGTAAGACAAGCAAGGAGA
CGCGGGAAGAATAAAGAACGGGAAAAGGACCGCAGCAAAGGAGTAAAGGATCCAGAAGCCCGCGAGCTT
ATTAAGAAAAAGAGAAACAGAAACAGGCAGAACAGACAAGAGAACAAATATTGGGACATCCAGATTGGA
TATCAGACCAGAGAGGTTATGTGCATTAACAAGACGGGGAAAGCTGCTGATTTAAGCTTTTGCCAGCAA
GAGAAGCTTCCAATGACCTTCCAGTCCTGTGTGATCACCAAAGAGTGCCAGGTTTCCGAGTGGTCAGAG
TGGAGCCCCTGCTCAAAAACATGCCATGACATGGTGTCCCCTGCAGGCACTCGTGTAAGGACACGAACC
ATCAGGCAGTTTCCCATTGGCAGTGAAAAGGAGTGTCCAGAATTTGAAGAAAAAGAACCCTGTTTGTCT
CAAGGAGATGGAGTTGTCCCCTGTGCCACGTATGGCTGGAGAACTACAGAGTGGACTGAGTGCCGTGTG
GACCCTTTGCTCAGTCAGCAGGACAAGAGGCGCGGCAACCAGACGGCCCTCTGTGGAGGGGGCATCCAG
ACCCGAGAGGTGTACTGCGTGCAGGCCAACGAAAACCTCCTCTCACAATTAAGTACCCACAAGAACAAA
GAAGCCTCAAAGCCAATGGACTTAAAATTATGCACTGGACCTATCCCTAATACTACACAGCTGTGCCAC
ATTCCTTGTCCAACTGAATGTGAAGTTTCACCTTGGTCAGCTTGGGGACCTTGTACTTATGAAAACTGT
AATGATCAGCAAGGGAAAAAAGGCTTCAAACTGAGGAAGCGGCGCATTACCAATGAGCCCACTGGAGGC
TCTGGGGTAACCGGAAACTGCCCTCACTTACTGGAAGCCATTCCCTGTGAAGAGCCTGCCTGTTATGAC
TGGAAAGCAGTGAGACTGGGAAACTGCGAGCCAGATAACGGAAAGGAGTGTGGTCCAGGCACGCAAGTT
CAAGAGGTTGTGTGCATCAACAGTGATGGAGAAGAAGTTGACAGACAGCTGTGCAGAGATGCCATCTTC
CCCATCCCTGTGGCCTGTGATGCCCCATGCCCGAAAGACTGTGTGCTCAGCACATGGTCTACGTGGTCC
TCCTGCTCACACACCTGCTCAGGGAAAACGACAGAAGGGAAACAGATACGAGCACGATCCATTCTGGCC
TATGCGGGTGAAGAAGGTGGAATTCGCTGTCCAAATAGCAGTGCTTTGCAAGAAGTACGAAGCTGTAAT
GAGCATCCTTGCACAGTGTACCACTGGCAAACTGGTCCCTGGGGCCAGTGCATTGAGGACACCTCAGTA
TCGTCCTTCAACACAACTACGACTTGGAATGGGGAGGCCTCCTGCTCTGTCGGCATGCAGACAAGAAAA
GTCATCTGTGTGCGAGTCAATGTGGGCCAAGTGGGACCCAAAAAATGTCCTGAAAGCCTTCGACCTGAA
ACTGTAAGGCCTTGTCTGCTTCCTTGTAAGAAGGACTGTATTGTGACCCCATATAGTGACTGGACATCA
TGCCCCTCTTCGTGTAAAGAAGGGGACTCCAGTATCAGGAAGCAGTCTAGGCATCGGGTCATCATTCAG
CTGCCAGCCAACGGGGGCCGAGACTGCACAGATCCCCTCTATGAAGAGAAGGCCTGTGAGGCACCTCAA
GCGTGCCAAAGCTACAGGTGGAAGACTCACAAATGGCGCAGATGCCAATTAGTCCCTTGGAGCGTGCAA
CAAGACAGCCCTGGAGCACAGGAAGGCTGTGGGCCTGGGCGACAGGCAAGAGCCATTACTTGTCGCAAG
CAAGATGGAGGACAGGCTGGAATCCATGAGTGCCTACAGTATGCAGGCCCTGTGCCAGCCCTTACCCAG
GCCTGCCAGATCCCCTGCCAGGATGACTGTCAATTGACCAGCTGGTCCAAGTTTTCTTCATGCAATGGA
GACTGTGGTGCAGTTAGGACCAGAAAGCGCACTCTTGTTGGAAAAAGTAAAAAGAAGGAAAAATGTAAA
AATTCCCATTTGTATCCCCTGATTGAGACTCAGTATTGTCCTTGTGACAAATATAATGCACAACCTGTG
GGGAACTGGTCAGACTGTATTTTACCAGAGGGAAAAGTGGAAGTGTTGCTGGGAATGAAAGTACAAGGA
GACATCAAGGAATGCGGACAAGGATATCGTTACCAAGCAATGGCATGCTACGATCAAAATGGCAGGCTT
GTGGAAACATCTAGATGTAACAGCCATGGTTACATTGAGGAGGCCTGCATCATCCCCTGCCCCTCAGAC
TGCAAGCTCAGTGAGTGGTCCAACTGGTCGCGCTGCAGCAAGTCCTGTGGGAGTGGTGTGAAGGTTCGT
TCTAAATGGCTGCGTGAAAAACCATATAATGGAGGAAGGCCTTGCCCCAAACTGGACCATGTCAACCAG
GCACAGGTGTATGAGGTTGTCCCATGCCACAGTGACTGCAACCAGTACCTATGGGTCACAGAGCCCTGG
AGCATCTGCAAGGTGACCTTTGTGAATATGCGGGAGAACTGTGGAGAGGGCGTGCAAACCCGAAAAGTG
AGATGCATGCAGAATACAGCAGATGGCCCTTCTGAACATGTAGAGGATTACCTCTGTGACCCAGAAGAG
ATGCCCCTGGGCTCTAGAGTGTGCAAATTACCATGCCCTGAGGACTGTGTGATATCTGAATGGGGTCCA
TGGACCCAATGTGTTTTGCCTTGCAATCAAAGCAGTTTCCGGCAAAGGTCAGCTGATCCCATCAGACAA
CCAGCTGATGAAGGAAGATCTTGCCCTAATGCTGTTGAGAAAGAACCCTGTAACCTGAACAAAAACTGC
TACCACTATGATTATAATGTAACAGACTGGAGTACATGTCAGCTGAGTGAGAAGGCAGTTTGTGGAAAT
GGAATAAAAACAAGGATGTTGGATTGTGTTCGAAGTGATGGCAAGTCAGTTGACCTGAAATATTGTGAA
GCGCTTGGCTTGGAGAAGAACTGGCAGATGAACACGTCCTGCATGGTGGAATGCCCTGTGAACTGTCAG
CTTTCTGATTGGTCTCCTTGGTCAGAATGTTCTCAAACATGTGGCCTCACAGGAAAAATGATCCGAAGA
CGAACAGTGACCCAGCCCTTTCAAGGTGATGGAAGACCATGCCCTTCCCTGATGGACCAGTCCAAACCC
TGCCCAGTGAAGCCTTGTTATCGGTGGCAATATGGCCAGTGGTCTCCATGCCAAGTGCAGGAGGCCCAG
TGTGGAGAAGGGACCAGAACAAGGAACATTTCTTGTGTAGTAAGTGATGGGTCAGCTGATGATTTCAGC
AAAGTGGTGGATGAGGAATTCTGTGCTGACATTGAACTCATTATAGATGGTAATAAAAATATGGTTCTG
GAGGAATCCTGCAGCCAGCCTTGCCCAGGTGACTGTTATTTGAAGGACTGGTCTTCCTGGAGCCTGTGT
CAGCTGACCTGTGTGAATGGTGAGGATCTAGGCTTTGGTGGAATACAGGTCAGATCCAGACCGGTGATT
ATACAAGAACTAGAGAATCAGCATCTGTGCCCAGAGCAGATGTTAGAAACAAAATCATGTTATGATGGA
CAGTGCTATGAATATAAATGGATGGCCAGTGCTTGGAAGGGCTCTTCCCGAACAGTGTGGTGTCAAAGG
TCAGATGGTATAAATGTAACAGGGGGCTGCTTGGTGATGAGCCAGCCTGATGCCGACAGGTCTTGTAAC
CCACCGTGTAGTCAACCCCACTCGTACTGTAGCGAGACAAAAACATGCCATTGTGAAGAAGGGTACACT
GAAGTCATGTCTTCTAACAGCACCCTTGAGCAATGCACACTTATCCCCGTGGTGGTATTACCCACCATG
GAGGACAAAAGAGGAGATGTGAAAACCAGTCGGGCTGTACATCCAACCCAACCCTCCAGTAACCCAGCA
GGACGGGGAAGGACCTGGTTTCTACAGCCATTTGGGCCAGATGGGAGACTAAAGACCTGGGTTTACGGT
GTAGCAGCTGGGGCATTTGTGTTACTCATCTTTATTGTCTCCATGATTTATCTAGCTTGCAAAAAGCCA
AAGAAACCCCAAAGAAGGCAAAACAACCGACTGAAACCTTTAACCTTAGCCTATGATGGAGATGCCGAC
ATGTAA

AGCGGACCGACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGAT
ATCCTGGATTACAAGGATGACGACGATAAG
GTTTAA
Restriction Sites SgfI-RsrII     
ACCN NM_015204
Insert Size 4974 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Note Plasmids are not sterile.  For experiments where strict sterility is required, filtration with 0.22um filter is required.
Reference Data
RefSeq NM_015204.2
RefSeq Size 10607 bp
RefSeq ORF 4974 bp
Locus ID 221981
UniProt ID Q9UPZ6
Protein Families Transmembrane
MW 185.4 kDa
Gene Summary The protein encoded by this gene is found almost exclusively in endothelial cells from placenta and umbilical cord. The encoded protein appears to interact with alpha(V)beta(3) integrin and paxillin to inhibit endothelial cell migration and tube formation. This protein may be involved in cytoskeletal organization. Variations in this gene may be associated with low bone mineral density in osteoporosis. [provided by RefSeq, Aug 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...